NMR structure of the water soluble Aβ17–34 peptide
Alzheimer's disease is the most common neurodegenerative disorder in the world. Its most significant symptoms are memory loss and decrease in cognition. Alzheimer's disease is characterized by aggregation of two proteins in the brain namely Aβ (amyloid β) and tau. Recent evidence suggests...
Main Authors: | Genadiy Fonar, Abraham O. Samson |
---|---|
Format: | Article |
Language: | English |
Published: |
Portland Press, Biochemical Society
2014-11-01
|
Series: | Bioscience Reports |
Subjects: | |
Online Access: | http://www.bioscirep.org/bsr/034/e155/bsr034e155.htm |
Similar Items
-
Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
by: Dietmar Rudolf Thal, et al.
Published: (2019-11-01) -
Exploring the Early Stages of the Amyloid Aβ(1–42) Peptide Aggregation Process: An NMR Study
by: Angelo Santoro, et al.
Published: (2021-07-01) -
Novel Benzothiazole-Based Ureas as 17β-HSD10 Inhibitors, A Potential Alzheimer’s Disease Treatment
by: Laura Aitken, et al.
Published: (2019-07-01) -
The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer’s disease
by: Tunahan Kirabali, et al.
Published: (2019-12-01) -
Aβ-40 Y10F Increases βfibrils Formation but Attenuates the Neurotoxicity of Amyloid-β Peptide
by: Zhaofeng Jiang, et al.
Published: (2012-04-01)